NR

NRC Health

NRCHealthcareNASDAQ

Health Information Services · Last scanned Jul 18, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$137.4M
-4.0% YoY
Net Income
$11.6M
-53.2% YoY
EBITDA
$30.2M
-26.8% YoY
Free Cash Flow
$19.7M

Scan Results

Daily timeframe
6 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 RSI OverboughtRSI 77.3, above 70, stock may be overbought
Jul 10 RSI OverboughtRSI 80.7, above 70, stock may be overbought
About NRC Health

Part of the healthcare sector, NRC Health (NRC) is listed under Health Information Services. The company carries a $490.8M market cap, placing it firmly in the small-cap category. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.

Key stats
Market Cap$490.8M
P/E (TTM)55.85
Fwd P/E20.36
EPS$0.39
Beta0.38
52W Change+53.2%
Dividend Yield2.73%
ROE41.9%
Analysis

The company holds $2.5M in cash, though total debt stands at $78.0M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $19.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 41.9%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 12.2% further supports the picture of efficient asset utilization. Revenue has been relatively flat, moving from $151.6M (2022) to $137.4M (2025).

The relatively low beta of 0.38 suggests NRC is a less volatile holding compared to the broader index. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence NRC Health's trajectory.

Links
More Healthcare stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms